Clinical Trials List
2024-09-30 - 2026-06-30
Phase II
Not yet recruiting5
Recruiting1
ICD-10N18.4
Chronic kidney disease, stage 4 (severe)
ICD-10N18.5
Chronic kidney disease, stage 5
ICD-10N18.6
End stage renal disease
ICD-10N18.9
Chronic kidney disease, unspecified
ICD-9585
Chronic renal failure
-
-
Trial Applicant
BAYER TAIWAN COMPANY LTD.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/05/13
Investigators and Locations
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 黃鏘綺 Division of Nephrology
- 李岳庭 Division of Nephrology
- 陳德全 Division of Nephrology
- Wen-Chin Lee Division of Nephrology
- 邱鼎育 Division of Nephrology
- 蔡凱帆 Division of Nephrology
- Chien-Hsing Wu Division of Nephrology
- 李隆志 Division of Nephrology
- CHIH-CHAO YANG Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- YUNG-HO HSU 無
- Mei-Yi Wu 無
- 高芷華 無
- I-jen Chiu Division of Nephrology
- Li-Yee Hong 無
- Cai-Mei Zheng Division of Nephrology
- 林冠宏 無
- Chia-Te Liao Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Co-Principal Investigator
- 呂金盈 Division of Endocrinology
- CHIH-YUAN WANG CHIH-YUAN WANG Division of Endocrinology
- - - Division of Nephrology
- 黃道民 Division of Nephrology
- SHUEI-LIONG LIN Division of Nephrology
The Actual Total Number of Participants Enrolled
0 Not yet recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
56 participants
-
Global
1400 participants
